Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months

BACKGROUND: Prognostication is very important to clinicians and families during the early management of severe traumatic brain injury (sTBI), however, there are no gold standard biomarkers to determine prognosis in sTBI. As has been demonstrated in several diseases, early measurement of serum metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Banoei, Mohammad M., Lee, Chel Hee, Hutchison, James, Panenka, William, Wellington, Cheryl, Wishart, David S., Winston, Brent W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363297/
https://www.ncbi.nlm.nih.gov/pubmed/37481590
http://dx.doi.org/10.1186/s13054-023-04573-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363297/
https://www.ncbi.nlm.nih.gov/pubmed/37481590
http://dx.doi.org/10.1186/s13054-023-04573-9

Ejemplares similares